Navigation Links
Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
Date:8/13/2008

EAST BRUNSWICK, N.J., Aug. 13 /PRNewswire/ -- At the upcoming Medical Grade Polymers Conference, Dr. Remi Thiria, Bluestar Silicones R&D Team Leader, will present "Silicone Elastomer Gels: New Soft Adhesives for Wound Care." The conference will take place in Philadelphia, September 16-17.

According to Dr. Thiria, silicones offer a wide variety of molecular structures that provide differentiated performance features for wound care, scar management and transdermal drug delivery.

"Adhesive silicone gels are ideal for wound care and transdermal applications for their physical properties and inherent biocompatibility," says Dr. Thiria. "The hydrophobic nature of these products enables gentle adhesion to dry skin without adhesion to moist skin, preventing secondary trauma to newly formed skin in a healing wound."

In his presentation, Dr. Thiria will explore new developments relating how linear viscoelastic response correlated to probe tack results can better control the performance requirements for wound care and transdermal applications.

Bluestar Silicones will host a tabletop display at the Medical Grade Polymers Conference highlighting its Silbione(R) brand adhesive silicone gels designed specifically for the wound care and transdermal applications. For more information, call 1-866-474-6342.

About Dr. Thiria

Dr. Remi Thiria is R&D team leader at Bluestar Silicones for elastomer technology formulation. Located in Rock Hill, S.C., Dr. Thiria has been with the company for nine years. He holds a Ph.D. in macromolecular materials and composites from the University of Lyon I in Lyon, France, with additional advanced study in materials science and polymer science.

Bluestar Silicones is a euro 610 million worldwide silicones raw material manufacturer established in 2007 through China National Bluestar Corporation's acquisition of Rhodia Silicones. Bluestar Silicones, which has manufacturing operations in all regions of the world, combines upstream silicon metal operations and capacity with downstream silicone market and applications expertise. As one of the world's leading fully integrated global silicones manufacturers with more than 50 years of silicone expertise, Bluestar Silicones offers a full-range of silicone products in the areas of release coatings, specialty elastomers, healthcare, textile coatings, specialty fluids, emulsions, and resins.

Press contact: Karen O'Keefe, Bluestar Silicones USA

Phone: 732-227-2089 -- Fax: 732-249-7000

E-mail: Karen.okeefe@bluestarsilicones.com


'/>"/>
SOURCE Bluestar Silicones
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Carl Marks Seeds New Healthcare Fund Through Strategic Partnership With BlueStar Capital Management
2. Bluestar Silicones Introduces Three New Soft and Durable Liquid Silicone Rubber Products
3. Bluestar Silicones Debuts New Soft Elastomers at Medical Device & Manufacturing East Expo
4. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
5. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
6. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
7. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
8. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
9. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
10. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
11. Arpida Presents Preclinical Data on AR-2474 at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
(Date:12/8/2016)... Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: ... develops and plans to commercialize innovative therapeutics for ... common stock were approved for trading on the ... on the OTCQX, effective today, under the ticker ... OTCQX market, companies must meet high financial standards, ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selectorâ„¢ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
Breaking Biology Technology:
(Date:12/2/2016)... December 1, 2016 The ... Voice), Future Technology (Iris Recognition System), Vehicle Type ... Global Forecast to 2021", published by MarketsandMarkets, the ... in 2016, and is projected to grow to ... of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... LiveWire Healthcare and Life Sciences Awards as "Most ... off an unprecedented year of recognition and growth for ... over 15 years. iMedNet ™ ...
Breaking Biology News(10 mins):